About 10 weeks after it was approved, the Wegovy pill is now estimated to be part of the daily regimen of about 400,000 Americans. And the field of weight-loss treatment is on the verge of even more ...

Lilly is betting big on retatrutide as the next pillar of its obesity portfolio after its weight loss injection Zepbound and ...

While Johnson & Johnson retains the top revenue rank across the major pharma companies, Eli Lilly last year established ...

Structure Therapeutics said its experimental pill helped people lose about 16% of their body weight after about a year of treatment Structure Therapeutics is one of several companies developing new ...

Analysts are intrigued by aleniglipron’s potential in the oral GLP-1RA market, though they say it's too early assess its market potential against orforglipron.

The global weight-loss drug market is entering a new phase, driven by the arrival of oral options, looming generic rivals and falling U.S. prices for blockbuster treatments from Eli Lilly and Novo ...

March 6 (Reuters) - The global weight-loss drug market is entering a new phase, driven by the arrival of oral options, looming generic rivals and falling U.S. prices for blockbuster treatments from ...

The FDA granted Priority Review to the BLA for Orca-T, an allogeneic stem cell and T-cell immunotherapy biologic for the treatment of hematological malignancies including acute myeloid leukemia, acute ...

Alex Hogan is STAT’s senior multimedia producer and host of STATus Report, STAT’s weekly video series. You can follow him on Bluesky. The era of GLP-1 weight loss ...

A clinical trial for diabetes that pit orforglipron, a diabetes and weight-loss pill developed by Eli Lilly, against oral semaglutide, made by Novo Nordisk, suggests the former pill may have the edge ...

Orforglipron, a novel oral nonpeptide GLP-1 receptor agonist (RA), led to a greater reduction in A1c and more significant weight loss compared to oral semaglutide in patients with type 2 diabetes (T2D ...

Add Yahoo as a preferred source to see more of our stories on Google. (Guido Mieth/DigitalVision/Getty Images) We may have a new champion when it comes to pills that can manage both blood sugar levels ...